SciELO - Scientific Electronic Library Online

 
vol.26 issue2Smoking in the population’s health at the Universidad Autónoma de Zacatecas, MexicoMandibular reconstruction with fibula flap microsurgical of the Institute of Child Health Specialist, Lima, Peru author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Acta Médica Peruana

On-line version ISSN 1728-5917

Abstract

BELTRAN GARATE, Brady et al. High-risk human papilloma virus in squamous cell esophageal cancer: a retrospective clinicopathologicalstudy from 2003 to 2006 in Edgardo Rebagliati-Martins Hospital, EsSalud, Lima, Peru. Acta méd. peruana [online]. 2009, vol.26, n.2, pp.83-85. ISSN 1728-5917.

Introduction: Human papilloma virus (HPV) is an agent involved in the pathophysiology of cervical cancer. Many reports describe an association between HPV and esophageal squamous-cell carcinoma (ESCC). Objective: The main objective of the study is to determine the frequency of high-risk HPV infection and ESCC. Material and method: A retrospective study including 29 ESCC cases with a histological and pathological diagnosis from 2003 to 2006 in Edgardo Rebagliati-Martins Hospital in Lima, Peru. Paraffin-embedded tissue fragments underwent RT-PCR tests for detecting HPV types 16, 18, 31, 33, and 45. Results: Mean age of patients was 73 years, male to female ratio was 3. Stage I disease was found in one case; stage II disease in 12 cases, stage III disease in 14 cases, and stage IV in 2. No highrigh HPV was found in any of the samples studied, even though we used two different probes.

Keywords : esophageal squamous cell cance; human papilloma virus; high risk.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License